Zantac owners Zantac hit the US market as a prescription drug in 1983 before transforming into an over-the-counter heartburn treatment in 1995. GSK and Warner Lambert developed it as part of a ...

GSK, Pfizer must face Zantac cases from about 75,000 consumers in Delaware, judge rules Zantac hit the US market as a prescription drug in 1983 before transforming into an over-the-counter ...

Zantac not a cause of woman’s cancer, jury says in first trial over drug By Diana Novak Jones May 23, 202411:47 AM PDTUpdated May 23, 2024 ...

The Pfizer settlements come as GSK, a previous Zantac manufacturer, defends itself in an ongoing trial, while Sanofi, which recalled the drug in 2019 over cancer claims, agreed to pay more than ...

Pharmaceutical company, Pfizer Inc. has agreed to settle more than 10,000 cases accusing the company of hiding the cancer risks of its heartburn drug, Zantac, Bloomberg reported Wednesday.

Sanofi has since returned Zantac to store shelves but without ranitidine. It is now made with famotidine, the active ingredient in competitor Pepcid. Originally Published: May 8, 2024 at 12:53 PM CDT ...

Pfizer settles over 10,000 Zantac-related cancer lawsuits, marking a significant legal agreement amidst concerns over NDMA contamination in the popular heartburn medication.

It’s now made with famotidine, the active ingredient in competitor Pepcid. Zantac is still one of the US’s leading heartburn treatments in a market that generated $14 billion in sales last year.

Sanofi SA said it has agreed to settle approximately 4,000 lawsuits accusing the French drugmaker of selling its Zantac heartburn medicine without warning patients that it could cause cancer.

French drugmaker Sanofi agrees to settle 4,000 Zantac cancer lawsuits in US state courts Sanofi now sells Zantac360, a reformulated heartburn medicine whose active ingredient is famotidine.

Sanofi reintroduced Zantac without ranitidine and is now using famotidine. Market-moving news hits Benzinga Pro first—get a 30-minute edge and save 60% this 4th of July.

Zantac, developed by GSK and Warner-Lambert, hit the US market as a prescription drug in 1983 before becoming an over-the-counter heartburn treatment in 1996. It was owned by several companies ...